BioCity, the Bioscience incubation specialist with locations in the East Midlands (BioCity and Medicity in Nottingham), the North West (BioHub at Alderley Park) and Scotland (BioCity Scotland at Newhouse), has announced a new investment fund, created following a significant contribution by AstraZeneca.
The £5 million fund will be managed by BioCity and will make equity investments, typically between £50,000 and £250,000, in life science companies based at Alderley Park, Cheshire.
BioCity Chairman, Dr Louis Nisbet explains:
The University of Southampton Science Park has announced a ten year, £2million tenancy agreement with Chilworth Technology Ltd for Phi House, the biggest on the Park to date. The deal was orchestrated by the Science Park team and its agent Vail Williams, along with Chilworth Technology’s agent BNP Paribas.
JDF Associates expertise enables RNF Digital Innovation to fund ground breaking indoor digital navigation system
Leading UK digital technology business, RNF Digital Innovation needed to secure funding to develop its market leading mobile application indoor navigation service SWiFT. The ground breaking app uses clients existing technology, such as smartphones and tablets, to help create a more enjoyable and productive user experience.
JDF Associates expertise enables Corium Solutions to fund Innovation research for new products with global potential.
International Chemical business Corium Solutions needed to secure funding to accelerate a research and development programme for its pioneering anti-fungal and anti-bacterial formula Micro-Fresh, and to patent a range of new products to expand into global markets.